ONTARGET had 25,620 patients enrolled and TRANSCEND had 5,926, and both included patients with and without diabetes.
ONTARGET试验有25620个病人参与，TRANSCEND试验有5926人，两者都包括糖尿病人和非糖尿病人。
ONTARGET had 25,620 patients enrolled and TRANSCEND had 5,926, and both included patients with and without diabetes.
ONTARGET试验有25620个病人参与，TRANSCEND试验有5926人，两者都包括糖尿病人和非糖尿病人。
应用推荐